Advertisement

Reactive Oxygen Species and the Central Nervous System

  • B. Halliwell

Summary

Radicals are species containing one or more unpaired electrons. The oxygen radical superoxide (O 2 - ) and the non-radical oxidants hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) are produced during normal metabolism and perform several useful functions. Excessive production of O 2 - and H2O2 can result in tissue damage, which often involves generation of highly reactive hydroxy 1 radical (· OH) and other oxidants in the presence of “catalytic” iron or copper ions. A major form of antioxidant defence is the storage and transport of iron or copper ions in forms that will not catalyze formation of reactive radicals. Tissue injury, e. g., by ischaemia or trauma, can cause increased iron availability and accelerate free radical reactions. This may be especially important in the brain, since areas of this organ are rich in iron and cerebrospinal fluid cannot bind released iron ions. Oxidative stress upon nervous tissue can produce damage by several interacting mechanisms, including rises in intracellular free Ca2+ and, possibly, release of excitatory amino acids. Recent suggestions that free radical reactions are involved in the neurotoxicity of aluminium and in damage to the substantia nigra in Parkinson’s disease are reviewed. Finally, the nature of antioxidants is discussed, with a suggestion that antioxidant enzymes and chelators of iron ions may be more generally useful protective agents than chain-breaking antioxidants. Careful precautions must be taken in the design of antioxidants for therapeutic use.

Keywords

Lipid Peroxidation Unpaired Electron Excitatory Amino Acid Free Radical Reaction Parkinsonian Brain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams JD Jr, Odunze IN (1991) Biochemical mechanisms of l-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain? Biochem Pharmacol 41: 1099–1105PubMedCrossRefGoogle Scholar
  2. Agardh CD, Zhang H, Smith ML, Siesjö BL (1991) Free radical production and ischemic brain damage: influence of postischemic oxygen tension. Int J Dev Neurosci 9: 127–138PubMedCrossRefGoogle Scholar
  3. Andorn AC, Bacon BR, Nguyen-hunh AT, Paolato SJ, Stitts JA (1988) Guanyl nucleotide interactions with dopaminergic binding sites labelled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding site. Mol Pharmacol 33: 155–162PubMedGoogle Scholar
  4. Archibald FS,Tyrce C (1987) Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys 256: 638–650PubMedCrossRefGoogle Scholar
  5. Aruoma OI, Halliwell B, Gajewski E, Dizdaroglu M (1991) Copper ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem J 273: 601–604PubMedGoogle Scholar
  6. Balentine JD (1982) Pathology of oxygen toxicity. Academic, New YorkGoogle Scholar
  7. Betz AL (1985) Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J Neurochem 44: 574–579PubMedCrossRefGoogle Scholar
  8. Betz AL, Randall J, Martz D (1991) Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia. Am J Physiol 260: H563–568PubMedGoogle Scholar
  9. Birchall JD, Chappell JS (1988) Aluminium, chemical physiology and Alzheimer’s disease. Lancet ii: 1008–1010CrossRefGoogle Scholar
  10. Blake DR,Winyard P, Lunec J,Williams A, Good PA, Gutteridge JMC, Rowley D, Halliwell B, Hider RC (1985) Cerebral and ocular toxicity induced by desferoxamine. QJ Med 219: 345–355Google Scholar
  11. Bolann BJ, Ulvik RJ (1990) On the limited ability of superoxide to release iron from ferritin Eur J Biochem 193: 899–904PubMedCrossRefGoogle Scholar
  12. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM (1987) Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262: 10438–10440PubMedGoogle Scholar
  13. Carney JM, Starke-Reed PE, Oliver CN, Landum RW, Cheng MS,Wu JF, Floyd RA (1991) Reversal of age-related charges in brain protein oxidation, decrease in enzyme activity, and loss, in temporal and spatial memory by chronic administration of the spin trapping compound N-tert-butyl-α-phenylnitrone Proc Natl Acad Sci USA 88: 3633–3636PubMedCrossRefGoogle Scholar
  14. Chan PH, Longar S, Fishman RA (1987) Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 21: 540–547PubMedCrossRefGoogle Scholar
  15. Chan PH, Chu L, Chen SF, Carlson EJ, Epstein CJ (1990) Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase. Stroke 21 (Suppl III): 80–82Google Scholar
  16. Cochrane CJ, Schraufstatter IV, Hyslop P, Jackson J (1988) Cellular and biochemical events in oxidant injury. In: Halliwell B (ed) Oxygen radicals and tissue injury. FASEB, pp 49–54Google Scholar
  17. Cohen G (1988) Oxygen radicals and Parkinson’s disease. In Oxygen Radicals and Tissue Ingury (ed. Haliwell, B) FASEB, pp 130–135Google Scholar
  18. Colton CA, Gilbert DL (1987) Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223: 284–288PubMedCrossRefGoogle Scholar
  19. Curnutte JT, Babior BM (1987) Chronic granulomatous disease. Adv Hum Genet 16: 229–297PubMedGoogle Scholar
  20. Davies MJ (1990) Detection of myoglobin-derived radicals on reaction of metmyoglobin with hydrogen peroxide and other peroxidic compounds. Free Radic Res Commun 10: 361–370PubMedCrossRefGoogle Scholar
  21. Demopoulos HB, Flamm E, Selligman M, Pietronigro DD (1982) Oxygen free radicals in central nervous system ischemia and trauma. In: Autor AP (ed) Pathology of oxygen. Academic, New York, pp 127–155Google Scholar
  22. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsen CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease. J Neurochem 52: 1830–1836PubMedCrossRefGoogle Scholar
  23. Dykens JA, Stern A,Trenkner E (1987) Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J Neurochem 49: 1222–1228PubMedCrossRefGoogle Scholar
  24. Esterbauer H (1985) Lipid peroxidation products: formation, chemical properties and biological activities. In: Poli G, Cheeseman KH, Dianzani MV, Slater TF (eds) Free radicals in liver injury. IRL, pp 29–47Google Scholar
  25. Frank DM, Arora PK, Blumer JL, Sayre LM (1987) Model study on the bioreduction of paraquat, MPP+ and analogs. Evidence against a “redox cycling” mechanism in MPTP neurotoxicity. Biochem Biophys Res Commun 147: 1095–1104PubMedCrossRefGoogle Scholar
  26. Frei B, England L, Ames BN (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86: 6377–6381PubMedCrossRefGoogle Scholar
  27. Fridovich I (1978) The biology of oxygen radicals. Science 209: 875–877CrossRefGoogle Scholar
  28. Gardner PR, Fridovich I (1991) Superoxide sensitivity of the Escherichia coli aconitase. J. Biol. Chem. 266: 19328–19333PubMedGoogle Scholar
  29. Gruener N, Gozlan O, Goldstein T, Davis J, Besner I, Iancu TC (1991) Iron, transferrin and ferritin in cerebrospinal fluid of children Clin Chem 37: 263–265PubMedGoogle Scholar
  30. Gutteridge JMC (1986) Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201: 291–295PubMedCrossRefGoogle Scholar
  31. Gutteridge JMC, Quinlan GJ, Clark IA, Halliwell B (1985) Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta 835: 441–447PubMedGoogle Scholar
  32. Hall ED (1988) Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats. J Neurosurg 68: 462–465PubMedCrossRefGoogle Scholar
  33. Hall ED, Braughler JM (1988 a) The role of oxygen radical-induced lipid peroxidation in acute central nervous system trauma. Oxygen radicals and tissue injury. (Halliwell, B ed) FASEB, pp 92–98Google Scholar
  34. Hall ED, Yonkers PA (1988 b) Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 19: 340–344PubMedCrossRefGoogle Scholar
  35. Hall ED, Yonkers PA, McCall JM (1988 a) Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F Eur J Pharmacol 147: 299–303PubMedCrossRefGoogle Scholar
  36. Hall ED, Yonkers PA, McCall JM, Braughler JM (1988 b) Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg 68: 456–461PubMedCrossRefGoogle Scholar
  37. Hall ED, Pazara KE, Braughler JM, Lineman KL, Jacobsen EJ (1990) Nonsteroidal lazaroid U78517F in models of focal and global ischemia. Stroke 21 (Suppl III): 83–87Google Scholar
  38. Halliwell B (1984) Manganese ions, oxidation reactions and the superoxide radical. Neuro-toxicology 5: 113–118Google Scholar
  39. Halliwell B (1987) Oxidants and human disease: some new concepts. FASEB J 1: 358–364PubMedGoogle Scholar
  40. Halliwell B (1989 a) Superoxide, iron, vascular endothelium and reperfusion injury. Free Radic Res Commun 5: 315–318PubMedCrossRefGoogle Scholar
  41. Halliwell B (1989b) Protection against tissue damage in vivo by desferoxamine. What is its mechanism of action? Free Radic Biol Med 7: 645–651PubMedCrossRefGoogle Scholar
  42. Halliwell B (1990) How to characterize a biological antioxidant. Free Radic Res Commun 9: 1–32PubMedCrossRefGoogle Scholar
  43. Halliwell B, Aruoma OI (1991) DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 281: 9–19PubMedCrossRefGoogle Scholar
  44. Halliwell B, Grootveld M (1987) The measurement of free radical reactions in humans. FEBS Lett 213: 9–14PubMedCrossRefGoogle Scholar
  45. Halliwell B, Gutteridge JMC (1984) Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet i: 1396–1398CrossRefGoogle Scholar
  46. Halliwell B, Gutteridge JMC (1986) Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 246: 501–504PubMedCrossRefGoogle Scholar
  47. Halliwell B, Gutteridge JMC (1989) Free radicals in biology and medicine, second edition. Clarendon, Oxford.Google Scholar
  48. Halliwell B, Gutteridge JMC (1990 a) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186: 1–85PubMedCrossRefGoogle Scholar
  49. Halliwell B, Gutteridge JMC (1990 b) The antioxidants of human extracellular fluids. Arch Biochem Biophys 280: 1–8PubMedCrossRefGoogle Scholar
  50. Halliwell B, Aruoma OI, Mufti G, Bomford A (1988 a) Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. FEBS Lett 241: 202–204PubMedCrossRefGoogle Scholar
  51. Halliwell B, Aruoma OI, Wasil M, Gutteridge JMC (1988 b) The resistance of transferrin, lactoferrin and caeruloplasmin to oxidative damage. Biochem J 256: 311–312PubMedGoogle Scholar
  52. Halliwell B, Grootveld M, Kaur H, Fagerheim I (1988 c) Aromatic hydroxylation and uric acid degradation as methods for detecting and measuring oxygen radicals in vivo and in vitro. In: Rice-Evans C, Halliwell B (eds) Free radicals: methodology and concepts. Richelieu, London, pp 33–59Google Scholar
  53. Halliwell B, Chirico S, Kaur H, Aruoma OI, Grootveld M, Blake DR (1992) Application of new assays for measuring free radical production to human rheumatoid patients. In: Davies KJA (ed) Oxidative damage and repair. Proceedings of the Pasadena conference. Pergamon, New York pp 846–855Google Scholar
  54. Hayaishi M, Slater TF (1986) Inhibitory effects of Ebselen on lipid peroxidation in rat liver microsomes. Free Radic Res Commun 2: 179–185CrossRefGoogle Scholar
  55. Heiskala H, Gutteridge JMC, Westermarck T, Alanen T, Santavuori P (1988) Bleomycin-detectable iron and phenanthroline-detectable copper in the cerebrospinal fluid of patients with neuronal ceroid-lipofuscinoses. Am J Med Genet (Suppl) 5: 193–202CrossRefGoogle Scholar
  56. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminium increase in the substantia nigra of patients with Parkinson’s disease: an X-ray microanalysis. J Neurochem 56: 446–451PubMedCrossRefGoogle Scholar
  57. Hope BT, Michael GJ, Knigge LM,Vincent SR (1991) Neuronal NADPH diaphorase is a nitric oxide synthetase Proc Natl Acad Sci USA 88: 2811–2814PubMedCrossRefGoogle Scholar
  58. Imlay JA, Linn S (1988) DNA damage and oxygen radical toxicity. Science 240: 1302–1309PubMedCrossRefGoogle Scholar
  59. Kanner J, German JB, Kinsella JE (1987) Initiation of lipid peroxidation in biological systems. Crit Rev Food Sci Nutr 25: 317–374PubMedCrossRefGoogle Scholar
  60. Kehrer JP (1989) Concepts related to the study of reactive oxygen and cardiac reperfusion injury. Free Radic Res Commun 5: 305–314PubMedCrossRefGoogle Scholar
  61. Komulainen H, Bondy SC (1988) Increased free intracellular Ca2+ by toxic agents; an index of potential neurotoxicity? Trends Pharmacol Sci 9: 154–156PubMedCrossRefGoogle Scholar
  62. Kyle ME, Nakae D, Sakaida I, Miccadei S, Farber JL (1988) Endocytosis of superoxide dismutase is required in order for the enzyme to protect hepatocytes from the cytotoxicity of hydrogen peroxide. J Biol Chem 263: 3784–3789PubMedGoogle Scholar
  63. Langston JW, Irwin I, Ricaurte GA (1987) Neurotoxins, Parkinsonism and Parkinson’s disease. Pharmcol Ther 32: 19–49CrossRefGoogle Scholar
  64. Laughton MJ, Halliwell B, Evans PJ, Hoult JRS (1989) Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxy 1 radical generation and bleomycin-dependent damage to DNA. Biochem Pharmacol 38: 2859–2865PubMedCrossRefGoogle Scholar
  65. Laurindo FRM, da Luz PL, Vint L, Rocha TF, Jaeger RG, Lopes EA (1991) Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation 83: 1705–1715PubMedGoogle Scholar
  66. Liccione JJ, Maines MD (1988) Selective vulnerability of glutathione metabolism and cellular defence mechanisms in rat striatum to manganese. J Pharmacol Exp Ther 247: 156–161PubMedGoogle Scholar
  67. Lim KH, Connolly M, Rose D, Siegman F, Jacobowitz I, Acinepura A, Cunningham JN Jr (1986) Prevention of reperfusion injury of the ischemic spinal cord: use of recombinant superoxide dismutase. Ann Thorac Surg 42: 282–286PubMedCrossRefGoogle Scholar
  68. Link EM (1988) The mechanism of pH-dependent hydrogen peroxide cytotoxicity in vitro. Arch Biochem Biophys 265: 362–372PubMedCrossRefGoogle Scholar
  69. Maly FE (1990) The B-lymphocyte: a newly-recognized source of reactive oxygen species with immunoregulatory potential. Free Radic Res Commun 8: 143–148PubMedCrossRefGoogle Scholar
  70. Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A (1986) Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Neurosci Lett 69: 192–197PubMedCrossRefGoogle Scholar
  71. McConkey DJ, Hartzeil P, Nicotera P, Wyllie AH, Orrenius S (1988) Stimulation of endogenous endonuclease activity in hepatocytes exposed to oxidative stress. Toxicol Lett 42: 123–130PubMedCrossRefGoogle Scholar
  72. McCord JM, Russell WJ (1988) Superoxide inactivates creatine Phosphokinase during reperfusion of ischemic heart. In: Cerutti PA, Fridovich I, McCord JM (eds) Oxy-radicals in molecular biology and pathology. Liss, New York, pp 27–35Google Scholar
  73. Meier B, Radeke H, Seile S, Raspe HH, Sies H, Resch K, Habermehl GG (1990) Human fibroblasts release reactive oxygen species in response to treatment with synovial fluids from patients suffering from arthritis. Free Radic Res Commun 8: 149–160PubMedCrossRefGoogle Scholar
  74. Meldrum B (1985) Excitatory amino acids and anoxic/ischaemic brain damage.Trends Neurosci 8: 47–48CrossRefGoogle Scholar
  75. Meneghini R (1988) Genotoxicity of active oxygen species in mammalian cells. Mutat Res 195: 215–230Google Scholar
  76. Michel HS,Vaishnav YN, Kempski O, von Lubitz D, Weiss JF, Feuerstein G (1987) Breathing 100% oxygen after global brain ischemia in Mongolian gerbils results in increased lipid peroxidation and increased mortality. Stroke 18: 426–430CrossRefGoogle Scholar
  77. Muakkassah-Kelly SF, Andresen JW, Shih JC, Hochstein P (1982) Decreased (3H)-serotonin and (3H)-assat-spiperone binding consequent to lipid peroxidation in rat cortical membranes. Biochem Biophys Res Commun 104: 1003–1010PubMedCrossRefGoogle Scholar
  78. Muller A, Cadenas R, Graf P, Sies H (1984) A novel biologically active seleno-organic compound: I. Glutathione peroxidase activity in vitro and anti-oxidant capacity of PZ51 (Ebselen). Biochem Pharmacol 33: 3235–3240PubMedCrossRefGoogle Scholar
  79. Murrell GAC, Francis MJO, Bromley L (1990) Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265: 659–665PubMedGoogle Scholar
  80. Pall HS, Williams AC, Blake DR, Lunec J, Gutteridge JMC, Hall M, Taylor A (1987) Raised cerebrospinal-fluid copper concentrations in Parkinson’s disease. Lancet ii: 238–241CrossRefGoogle Scholar
  81. Patt A, Harkam AH, Burton LK, Rodell TC, Piermattei D, Schorr WJ, Parker NB, Berger EM, Horesh IR,Terada LS, Linas SL, Cheronic JC, Repine JE (1988) Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains. J Clin Invest 81: 1556–1562PubMedCrossRefGoogle Scholar
  82. Pellegrini-Giampietro DE, Cherichi G, Alesiani M, Carla V, Moroni F (1988) Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation. J Neurochem 51: 1961–1963CrossRefGoogle Scholar
  83. Puppo A, Halliwell B (1988) Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton catalyst? Biochem J 249: 185–190PubMedGoogle Scholar
  84. Puppo A, Halliwell B (1989) Oxidation of dimethylsulphoxide to formaldehyde by oxy-haemoglobin and oxyleghaemoglobin in the presence of hydrogen peroxide is not mediated by “free” hydroxyl radicals. Free Radic Res Commun 5: 277–281PubMedCrossRefGoogle Scholar
  85. Quinlan GJ, Halliwell B, Moorhouse CP, Gutteridge JMC (1988) Action of lead(II) and aluminium(III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. Biochim Biophys Acta 962: 196–200PubMedGoogle Scholar
  86. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls.The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244–4250PubMedGoogle Scholar
  87. Riederer P, Sofic E, Rausche WD, Schmidt B, Reynolds GP, Jallinger K,Youdim MBH (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J Neurochem 52: 515–520PubMedCrossRefGoogle Scholar
  88. Rosen AD, Frumin NV (1979) Focal epileptogenesis following intracortical haemoglobin injection. Exp Neurol 66: 277–284PubMedCrossRefGoogle Scholar
  89. Sarafian T, Verity MA (1991) Oxidative mechanisms underlying methyl mercury neurotoxicity Int J Dev Neurosci 9: 147–153PubMedCrossRefGoogle Scholar
  90. Saran M, Michel C, Bors W (1990) Reaction of NO with O2-. Implications for the action of endothelium-derived relaxing factor. Free Radic Res Commun 10: 221–226PubMedCrossRefGoogle Scholar
  91. Schor NF (1988) Inactivation of mammalian brain glutamine synthetase by oxygen radicals. Brain Res 456: 17–21PubMedCrossRefGoogle Scholar
  92. Shapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J Neurochem 55: 2142–2145CrossRefGoogle Scholar
  93. Sies H (1991) Oxidative stress, oxidants and antioxidants. Academic Press, New YorkGoogle Scholar
  94. Siesjö BK (1988) Mechanisms of ischemic brain damage. Crit Care Med 16: 954–963PubMedCrossRefGoogle Scholar
  95. Siesjö BK (1990) Calcium, excitotoxins and brain damage. NIPS 5: 120–125Google Scholar
  96. Siesjö BK, Bendek G, KoideT,Westerberg E, Wieloch T (1985) Influence of acidosis on lipid peroxidation in brain tissues in vitro. J Cereb Blood Flow Metab 5: 153–158Google Scholar
  97. Singer TP, Trevor AJ, Castagnoli N Jr (1987) Biochemistry of the neurotoxic action of MPTR Trends Biochem Sci 12: 266–270CrossRefGoogle Scholar
  98. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. J Neurochem 56: 978–982PubMedCrossRefGoogle Scholar
  99. Sotomatsu A, Nakano M, Hirai S (1990) Phospholipid peroxidation induced by the catechol-Fe3+ (Cu2+) complex: a possible mechanism of nigrostriatal cell damage. Arch Biochem Biophys 283: 334–341PubMedCrossRefGoogle Scholar
  100. Spector R, Eells J (1984) Deoxynucleoside and vitamin transport into the central nervous system. Fed Proc 43: 196–200PubMedGoogle Scholar
  101. Stankovic A, Mitrovic DR (1991) Aluminium salts stimulate luminol-enhanced chemilumi-nescence production by human neutrophils. Free Radic Res Commun 14: 47–55PubMedCrossRefGoogle Scholar
  102. Steele JA, Stockbridge N, Maljkovic G, Weir B (1991) Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circulation Research 68: 416–423PubMedGoogle Scholar
  103. Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL (1974) The inhibition of lipid autoxidation by human serum and its relationship to serum proteins and alpha-tocopherol. Clin Sci 47: 223–233Google Scholar
  104. Touati D (1989) The molecular genetics of superoxide dismutase in E. coli. An approach to understanding the biological role and regulation of SODs in relation to other elements of the defence system against oxygen toxicity. Free Radic Res Commun 8: 1–9PubMedCrossRefGoogle Scholar
  105. Turrens JF, Crapo JD, Freeman BA (1984) Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 73: 87–95PubMedCrossRefGoogle Scholar
  106. Turski L, Bressler K, Rettig KJ, Loschman PA,Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349: 414–418PubMedCrossRefGoogle Scholar
  107. Van Loon APGM, Pesold-Hurt B, Schatz G (1986) A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc Natl Acad Sci USA 83: 3820–3824PubMedCrossRefGoogle Scholar
  108. Watson BD, Ginsberg MD (1988) Mechanism of lipid peroxidation potentiated by ischemia in the brain. In Oxygen radicals and tissue injury. (Halliwell B ed) FASEB, pp 81–91Google Scholar
  109. Weiner WJ, Nausieda PA, Klawans HL (1977) Effect of chlorpromazine on central nervous system concentrations of manganese, iron and copper. Life Sci 20: 1181–1186PubMedCrossRefGoogle Scholar
  110. Willmore LJ, Ballinger WE, Boggs W, Sypert GW, Rubin JJ (1980) Dendritic alterations in rat isocortex within an iron-induced chronic epileptic focus. Neurosurgery 7: 142–146PubMedCrossRefGoogle Scholar
  111. Willmore LJ,Triggs WJ, Gray JD (1986) The role of iron-induced hippocampal peroxidation in acute epileptogenesis. Brain Res 382: 422–426PubMedCrossRefGoogle Scholar
  112. Youdim MBH (1988 a) Brain iron. Neurochemical and behavioural aspects.Taylor and Francis, New YorkGoogle Scholar
  113. Youdim MBH (1988 b) Iron in the brain: implications for Parkinson’s and Alzheimer’s diseases. Mt Sinai J Med 55: 97–101PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • B. Halliwell

There are no affiliations available

Personalised recommendations